| Literature DB >> 35977514 |
Lorenzo Gesuita1, Anna Cavaccini1, Ali Özgür Argunsah1, Emilia Favuzzi2, Leena Ali Ibrahim2, Tevye Jason Stachniak1, Martina De Gennaro1, Sebastian Utz3, Melanie Greter3, Theofanis Karayannis4.
Abstract
Microglia play a key role in shaping the formation and refinement of the excitatory network of the brain. However, less is known about whether and how they organize the development of distinct inhibitory networks. We find that microglia are essential for the proper development of somatostatin-positive (SST+) cell synapses during the second postnatal week. We further identify a pair of molecules that act antagonistically to one another in the organization of SST+ cell axonal elaboration. Whereas CX3CL1 acts to suppress axonal growth and complexity, CXCL12 promotes it. Assessing the functional importance of microglia in the development of cortical activity, we find that a whisker stimulation paradigm that drives SST+ cell activation leads to reduced cortical spiking in brains depleted of microglia. Collectively, our data demonstrate an important role of microglia in regulating the development of SST+ cell output early in life.Entities:
Keywords: CP: Neuroscience; cerebral cortex; development; inhibitory synapses; interneurons; microglia; somatostatin
Mesh:
Substances:
Year: 2022 PMID: 35977514 PMCID: PMC9396528 DOI: 10.1016/j.celrep.2022.111209
Source DB: PubMed Journal: Cell Rep Impact factor: 9.995
Figure 1Microglia regulate the density of SST+ synapses during the second postnatal week
(A) Microglia (Iba1+) staining in S1 L2/3 of a P11 brain section from an SSTCre/+;Ai14Tg/+ mouse (scale bar: 100 μm). In the enlargements of the dashed boxes on the right, an example of microglia process-SST+ process apposition (full arrowhead) and of microglia process-SST+ soma apposition (empty arrowhead) are shown. Putative process-process appositions are quantified as total volume of colocalized signal divided by total SST+ process volume per field of view (each dot is a brain; P4 n = 3, P8 n = 6, P11 n = 3; t test: P4 versus P8 p = 0.0143, P8 versus P11 p = 0.8447, P4 versus P11 p = 0.0044; one-way ANOVA test p = 0.049).
(B) Images and 3D reconstruction of microglia processes contacting SST+ presynaptic boutons (GAD65+ puncta encased in GFP+ axons labeled using a SSTCre/+;RCE mouse) in S1 L1 (scale bar: 1 μm). Percentage of SST+ boutons contacted by microglia (each dot is a brain; P10 n = 6, P12 n = 3, P15 n = 6; t test: P10 versus P12 p = 0.071, P12 versus P15 p = 0.701, P10 versus P15 p = 0.011; one-way ANOVA test p = 0.015).
(C) Microglia staining in S1 of a control and a microglia-depleted brain section at P10 (scale bar: 100 μm; pia surface is indicated by a dotted line).
(D) Images and quantitation of SST+ synapses (GAD65+ and Gephyrin+ puncta encased in GFP+ axons labeled using a SSTCre/+;RCE mouse) in L1 of S1 at P15 (scale bar: 1 μm); arrowheads indicate colocalization (each dot is a brain; P10 control [CTRL] n = 4, PLX n = 7, t test p = 0.1; P12 CTRL n = 3, PLX n = 5, t test p = 0.63; P15 CTRL n = 6, PLX n = 4, t test p = 0.038).
(E) A schematic of subpial electroporation and microglia depletion protocol. The vertical black lines denote the manipulation intitiation (P2) and analysis time points (P10 and P15). Below is the map of the plasmid.
(F) Example of parts of traced axons (scale bar: 12.5 μm). Puncta density is calculated as total number of counted puncta divided by total length of traced axons per cell (each dot is a cell; P10 CTRL n = 9, PLX n = 9, t test p = 0.9; P15 CTRL n = 17, PLX n = 14, t test p = 0.0015; P10 CTRL versus P15 CTRL t test p = 0.00061; P10 PLX versus P15 PLX t test p = 0.64).
(G) Examples of traced cells (axons in red, dendrites in blue).
(H) Total length of traced axons (each dot is a cell; CTRL n = 11, PLX n = 12 cells, t test p = 0.42) and Sholl analysis (t test p values are plotted below; two-way ANOVA repeated measures (RM) test from 8 to 300 μm p = 0.96; CTRL group from Figure 2G, PLX group from Figure 2H).
(I) A schematic representation of the optogenetics experiment. IPSC traces and peak amplitude quantification (each dot is a cell; CTRL n = 15, PLX n = 15, t test p = 0.025).
All data are represented as mean ± SEM, and the exact values are reported in Table S1.
See also Figure S1.
Figure 2CX3CL1 and CXCL12 are key molecular players of microglia-dependent development of SST+ cells
(A) Schematics of the in silico screening.
(B) Lists of putative interactors. Line thickness is proportional to STRING confidence score (a score of 1,000 indicates the highest confidence of interaction).
(C) Cx3cl1 and Cxcl12 expression levels (RNA sequencing data from Favuzzi et al., 2019).
(D) Schematics of the subpial electroporation protocol and timeline. Below are the maps of the plasmids.
(E) Examples of parts of traced axons (scale bar: 12.5 μm). Puncta density is calculated as total number of counted puncta divided by total length of traced axons per cell (each dot is a cell; CTRL n = 8, Cx3cl1 cKO n = 11, Cxcl12 cKO n = 12; t test: CTRL versus Cx3cl1 cKO p = 0.55, CTRL versus Cxcl12 cKO p = 0.29; one-way ANOVA test p = 0.53).
(F) Examples of traced cells (axons in red, dendrites in blue). Below is the total length of traced axons (each dot is a cell; CTRL n = 11, Cx3cl1 cKO n = 9, t test p = 0.019) and Sholl analysis (t test p values are plotted below; two-way ANOVA RM test from 8 to 200 μm p = 0.018).
(G) Examples of traced cells. Below is the total length of traced axons (CTRL n = 11, Cxcl12 cKO n = 12, t test p = 0.08) and Sholl analysis (t test p-values are plotted below; two-way ANOVA RM test from 90 to 250 μm p = 0.05).
(H) Examples of traced cells. Below is the total length of traced axons (CTRL + PLX n = 12, Cx3cl1 cKO + PLX n = 9, Cxcl12 cKO + PLX n = 12; t test: CTRL + PLX versus Cx3cl1 cKO + PLX p = 0.43, CTRL + PLX versus Cxcl12 cKO + PLX p = 0.37; one-way ANOVA test p = 0.27) and Sholl analysis (t test p values are plotted below; two-way ANOVA RM test from 8 to 300 μm p = 0.3).
(I) Schematics of the subpial electroporation protocol. Below are the maps of the plasmids.
(J) An example of an electroporated cell at P15 (scale bar: 50 μm; pia surface is indicated by the dotted line).
(K) Schematics of the optogenetics experiment.
(L) Average traces of maximum amplitude of evoked IPSCs.
(M) Peak amplitude quantification (each dot is a cell; CTRL n = 6 cells from 4 mice, Cx3cl1 cKO n = 11 cells from 6 mice, Cxcl12 cKO n = 7 cells from 4 mice; t test: CTRL versus Cx3cl1 cKO p = 0.79, CTRL versus Cxcl12 cKO p = 0.29; one-way ANOVA test p = 0.7).
(N) Quantification of the number of pyramidal neurons responding to a single activated SST+ cell (each dot is the percentage of connected pyramidal neurons per single stimulated SST+ cell; CTRL n = 9, Cx3cl1 cKO n = 8, Cxcl12 cKO n = 7; Wilcoxon test: CTRL versus Cx3cl1 cKO p = 0.004, CTRL versus Cxcl12 cKO p = 0.26; Kruskal-Wallis test p = 0.032).
All data are represented as mean ± SEM, and the exact values are reported in Table S1.
See also Figure S2.
Figure 3Microglia depletion in the second postnatal week leads to reduced sensory-driven activation of the cortical network
(A–C) Average firing rate (Hz) of L2/3, L4, and L5/6 at baseline, without any whisker stimulation.
(D–I) Average traces of MUA evoked by multi-whisker stimulation at low and high frequencies; the blue arrows indicate whisker deflection. “Total” and “late” area under the curves (AUCs) are measured as indicated in the STAR Methods.
Each dot is a mouse. CTRL n = 8, PLX n = 4; (A) t test p = 0.61; (B) t test p = 0.28; (C) t test p = 0.18; (D′) Wilcoxon test p = 0.004; (D′′) t test p = 0.064; (E′) t test p = 0.081; (E′′) t test p = 0.12; (F′) t test p = 0.027; (F′′) t test p = 0.12; (G′) t test p = 0.15; (G′′) t test p = 0.034; (H′) t test p = 0.44; (H′′) t test p = 0.5; (I′) Wilcoxon test p = 0.15; (I′′) Wilcoxon test p = 0.15. Representative examples of silicon probe recordings are reported in Figure S3.
All data are represented as mean ± SEM, and the exact values are reported in Table S1.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| anti-Digoxigenin-POD, Fab fragments | Roche | Cat#11207733910; RRID: |
| chicken anti-GFP | Aves Lab | Cat#1020; RRID: |
| goat anti-tdTomato | Sicgen | Cat#AB8181, RRID: |
| mouse anti-GAD65 | Millipore | Cat#MAB351R; RRID: |
| mouse anti-Gephyrin | Synaptic Systems | Cat#147 011; RRID: |
| rabbit anti-Cleaved Caspase-3 (Asp175) | Cell Signaling | Cat#9661; RRID: |
| rabbit anti-Iba1 | Wako Chemicals | Cat#019–19741; RRID: |
| rabbit anti-mouse Collagen IV | Bio-Rad | Cat#2150–1470; RRID: |
| 4-aminopyradine | Tocris | Cat#0940 |
| Acetic anhydride 98% | Sigma-Merck | Cat#242845 |
| Acrylic dental cement | Kulzer | Cat#K010103 |
| Blocking reagent (Roche) | Roche | Cat#11096176001 |
| CaCl2 | Sigma-Merck | Cat#C8106 |
| Cs-methanosulfonate | Sigma-Merck | Cat#C1426 |
| CsCl | Sigma-Merck | Cat#289329 |
| CsMeSO3 | Sigma-Merck | Cat#C1426 |
| CsOH | Sigma-Merck | Cat#232041 |
| Cyanoacrylate glue | Permabond | Permabond 102 |
| D-(+)-Glucose | Sigma-Merck | Cat#G5767 |
| Denhardt’s solution | Invitrogen | Cat#750018 |
| DiI | Invitrogen | Cat#D282 |
| Dimethyl sulfoxide (DMSO) | Sigma-Merck | Cat#276855 |
| EGTA | Sigma-Merck | Cat#324626 |
| Fast green | Sigma-Merck | Cat#F7252 |
| Fluoromount-G™ Mounting Medium, with DAPI | Invitrogen | Cat#00-4959-52 |
| Formaldehyde solution 36.5–38% | Sigma-Merck | Cat#F8775 |
| Formamide | Acros Organics | Cat#AC181090010 |
| HCl 37% | Sigma-Merck | Cat#339253 |
| HEPES | Sigma-Merck | Cat#H3375 |
| Hydrogen peroxide solution | Sigma-Merck | Cat#107209 |
| KCl | Sigma-Merck | Cat#P9541 |
| Maleic acid | Sigma-Merck | Cat#M0375 |
| Methanol | Sigma-Merck | Cat#34885 |
| MgATP | Sigma-Merck | Cat#A9187 |
| MgCl2 | Sigma-Merck | Cat#M2393 |
| Na2-ATP | Sigma-Merck | Cat#10127531001 |
| Na3-GTP | Sigma-Merck | Cat#G8877 |
| NaCl | Sigma-Merck | Cat#S3014 |
| NaH2PO4 | Sigma-Merck | Cat#S0751 |
| NaHCO3 | Sigma-Merck | Cat#S8875 |
| Normal Donkey Serum | Abcam | Cat#ab7475 |
| OCT | Sakura | Cat#4583 |
| PBS | Sigma-Merck | Cat#P4417 |
| PFA | Sigma-Merck | Cat#441244 |
| Phosphocreatine-Tris | Sigma-Merck | Cat#P1937 |
| PLX5622 powder | Chemgood | Cat#C-1521 |
| Proteinase K | Invitrogen | Cat#AM2548 |
| QX-314-Cl | Tocris | Cat#2313 |
| Ringer Solution | BBraun | Cat#3570010 |
| Salmon sperm | Invitrogen | Cat#15632011 |
| SSC | Invitrogen | Cat#15557–036 |
| Sucrose | Sigma-Merck | Cat#S0389 |
| trans-1,2-Cyclohexanediol (TCHD) | Sigma-Merck | Cat#141712 |
| Triethanolamine >99.5% | Sigma-Merck | Cat#90278 |
| Tris | Biosolve | Cat#0020092391BS |
| Triton™ X-100 | Sigma-Merck | Cat#T8787 |
| TSA Plus Cyanine 5 system | Akoya biosciences | Cat#NEL745001KT |
| TTX | Tocris | Cat#1078 |
| Tween® 20 | Sigma-Merck | Cat#P9416 |
| Yeast tRNA | Invitrogen | Cat#AM7118 |
| QIAGEN DNeasy Blood & Tissue Kit | QIAGEN | Cat#69504 |
| Transcriptomic postnatal data of microglia cells | GEO DataSets | |
| Transcriptomic postnatal data of neuronal cell types | GEO DataSets | |
| STRING protein-protein interaction database v11.0 | ( | |
| Ai14 (B6;129S6-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J) | Jackson Laboratories | Cat#007908; RRID:IMSR_JAX:007908 |
| Ai32 (B6.Cg-Gt(ROSA)26Sortm32(CAG−COP4∗H134R/EYFP)Hze/J) | Jackson Laboratories | Cat#024109; RRID:IMSR_JAX:024109 |
| C57BL/6JRj | Janvier | N/A |
| SST-IRES-Cre (Ssttm2.1(cre)Zjh/J) | Jackson Laboratories | Cat#013044; RRID:IMSR_JAX:013044 |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| Microsynth AG | N/A | |
| AAV phSyn1(S)-FLEX-tdTomato-T2A-SypEGFP-WPRE | ( | Addgene #51509; RRID:Addgene_51509 |
| p3E-2a-tdTomato | ( | Addgene #67707; RRID:Addgene_67707 |
| pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA | a gift from Karl Deisseroth | Addgene #20298; RRID:Addgene_20298 |
| pCAG_loxP-STOP-loxP-ChR2(H134R)-T2A-GFP | this manuscript | N/A |
| pCAG_loxP-STOP-loxP-GFP | this manuscript | N/A |
| pCAG_loxP-STOP-loxP-mSynaptophysin::GFP | this manuscript | N/A |
| pCAG_loxP-STOP-loxP-tdTomato-T2A-mSynaptophysin::GFP | this manuscript | N/A |
| pCAG-GFP | ( | Addgene #11150; RRID:Addgene_11150 |
| pCALNL-DsRed | ( | Addgene #13769; RRID:Addgene_13769 |
| pX333 | ( | Addgene #64073; RRID:Addgene_64073 |
| pX333_U6-gRNA-U6-gRNA-CBh-loxP-STOP-loxP-Cas9-2A-tdTomato | this study | N/A |
| pCLAMP v9.0–10.7.0.3 | Molecular Devices | |
| ImageJ – Fiji 2.1.0/1.53c | ( | |
| Imaris 9.3.1/9.5.0 | Bitplane | |
| MATLAB R2019a - 2021b | MathWorks | |
| MC_RACK software | Multi Channel Systems | |
| RStudio 1.2.1335 | RStudio Team (2018) | |
| Putative interaction counting code | this manuscript | |
| Synaptic bouton counting code | this manuscript | |
| Computational pipeline for protein-protein interactions | this manuscript | |
| 64-channel silicon probe | Neuronexus | Cat#A8x8-Edge-5mm-100-200-177-A64 |
| SuperFrost® Plus | Thermo Scientific | Cat#J1800AMNZ |